shutterstock_206660557

European Patent Office announces to grant sphingotec’s bio-ADM patent

The European Patent Office just announced its intention to grant sphingotec’s patent “Adrenomedullin Assays and Methods for Determining Mature Adrenomedullin” (EP12791143) that comprehensively protects the commercial use of sphingotest® bio-ADM.